| Original language | English |
|---|---|
| Pages (from-to) | 107-109 |
| Number of pages | 3 |
| Journal | Parkinsonism and Related Disorders |
| Volume | 77 |
| DOIs | |
| Publication status | Published - Aug 2020 |
| Externally published | Yes |
Keywords
- Gait analysis
- Multiple system atrophy
- Orthostatic hypotension
- Parkinson's disease
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Parkinsonism and Related Disorders, Vol. 77, 08.2020, p. 107-109.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - The footprint of orthostatic hypotension in parkinsonian syndromes
AU - Raccagni, Cecilia
AU - Sidoroff, Victoria
AU - Goebel, Georg
AU - Granata, Roberta
AU - Leys, Fabian
AU - Klucken, Jochen
AU - Eskofier, Bjoern
AU - Richer, Robert
AU - Seppi, Klaus
AU - Wenning, Gregor K.
AU - Fanciulli, Alessandra
N1 - Funding Information: Gregor K. Wenning: Dr Wenning reports personal fees from Alterity Therapeutics , Biogen , Biohaven , Gain Therapeutics , Lundbeck , Minoryx , Ono , Theravance , and UCB , honoraria from the Austrian Autonomic Society , Austrian Parkinson Society , Royalties from Cambridge University Press and Springer , research grants from FWF Austrian Science Fund , International Parkinson and Movement Disorder Society , and US MSA Coalition , outside of the submitted work. Funding Information: Alessandra Fanciulli: Dr Fanciulli reports royalties from Springer Nature , speaker fees and honoraria from the Ordensklinikum Linz , Austrian Parkinson Society , International Parkinson Disease and Movement Disorder Society and Theravance Biopharma and research grants from the Stichting ParkinsonFond , the MSA Coalition and the Österreichischer Austauschdienst , outside of the submitted work. Funding Information: Klaus Seppi: Dr. Seppi reports personal fees from Teva , UCB , Lundbeck , AOP Orphan Pharmaceuticals AG , Roche , Grünenthal , and Abbvie ; honoraria from the International Parkinson and Movement Disorders Society ; research grants from the FWF Austrian Science Fund , Michael J. Fox Foundation , and International Parkinson and Movement Disorder Society outside the submitted work. Funding Information: This study was supported by the MSA Coalition and performed at the Department of Neurology of the Medical University of Innsbruck, Austria.Jochen Klucken: Dr Klucken reports institutional research grants from EIT-Health; EIT-Digital; EU (H2020), German Research Foundation (DFG). Industry sponsored institutional IITs and grants from Alpha-Telemed AG. Compensation and honoraria from serving on scientific advisory boards and lecturing from Ever Neuro Pharma GmbH, TEVA Pharma GmbH, Bial Deutschland GmbH; Celgene GmbH, and Magisan GmbH.Bjoern Eskofier: BE holds ownerships of Portabiles HealthCare Technologies GmbH and Portabiles GmbH, received compensation and honoraria from serving on scientific advisory boards for Adidas AG, Siemens Healthineers AG, Siemens AG, and ST Sportservice GmbH. Further, he gratefully acknowledges the support of the German Research Foundation (DFG) within the framework of the Heisenberg professorship programme (grant number ES 434/8-1).Klaus Seppi: Dr. Seppi reports personal fees from Teva, UCB, Lundbeck, AOP Orphan Pharmaceuticals AG, Roche, Gr?nenthal, and Abbvie; honoraria from the International Parkinson and Movement Disorders Society; research grants from the FWF Austrian Science Fund, Michael J. Fox Foundation, and International Parkinson and Movement Disorder Society outside the submitted work.Gregor K. Wenning: Dr Wenning reports personal fees from Alterity Therapeutics, Biogen, Biohaven, Gain Therapeutics, Lundbeck, Minoryx, Ono, Theravance, and UCB, honoraria from the Austrian Autonomic Society, Austrian Parkinson Society, Royalties from Cambridge University Press and Springer, research grants from FWF Austrian Science Fund, International Parkinson and Movement Disorder Society, and US MSA Coalition, outside of the submitted work.Alessandra Fanciulli: Dr Fanciulli reports royalties from Springer Nature, speaker fees and honoraria from the Ordensklinikum Linz, Austrian Parkinson Society, International Parkinson Disease and Movement Disorder Society and Theravance Biopharma and research grants from the Stichting ParkinsonFond, the MSA Coalition and the ?sterreichischer Austauschdienst, outside of the submitted work.We thank our patients and families and the MSA Coalition for supporting this research. Bjoern Eskofier gratefully acknowledges the support of the German Research Foundation (DFG) within the framework of the Heisenberg professorship program (grant number ES 434/8-1). Funding Information: We thank our patients and families and the MSA Coalition for supporting this research. Bjoern Eskofier gratefully acknowledges the support of the German Research Foundation (DFG) within the framework of the Heisenberg professorship program (grant number ES 434/8-1).
PY - 2020/8
Y1 - 2020/8
KW - Gait analysis
KW - Multiple system atrophy
KW - Orthostatic hypotension
KW - Parkinson's disease
UR - http://www.scopus.com/inward/record.url?scp=85088221565&partnerID=8YFLogxK
U2 - 10.1016/j.parkreldis.2020.06.029
DO - 10.1016/j.parkreldis.2020.06.029
M3 - Letter
C2 - 32712561
AN - SCOPUS:85088221565
SN - 1353-8020
VL - 77
SP - 107
EP - 109
JO - Parkinsonism and Related Disorders
JF - Parkinsonism and Related Disorders
ER -